The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
One thing I have realised is if you buy a share don't listen to some of the nonsense been influenced on here if you buy into a share your buying to make money.
Imo boo hoo will rise so hold or buy at this price the way this stock is going a 10% rise easily buy next week is nearly there now from last week.
Good luck all.
Small drop before results which happens in most stocks as they know results day onwards is going to be a massive short squeeze. They know Mike Ashley has 10.5% or 40 million £ recently , rumours are he wants more.Rumours also of an Asos boohoo merger! They know the owners son bought 3% recently.All before results!
So basically nibbling at reducing the price b4 the rise of 10-15p imo.
Is this the end of the dip back to the upper 40s i hope
Due to the volatile market all shares are up and down the only serious advice I will give is hold onto your shares if your losing hold you only lose when you sell boohoo are in a not bad situation just remember derampers will always win if you sell hold on to the roller coaster ride and watch your share price increase.
well i had shares here for a long while i sold at a good gain but here i am again hoping this company will make me money again i have invested not large amounts over the last week so im holding now and hope to see this back upto £2 soon gla. in my opinion this share is too low it has its difficulty's like most company's at moment but this should start creeping up shortly gla.
So boohoo are hitting targets and trying to rectify keeping costs down by charging for returns cant wait for the next rns
as in my opinion this is way to low.
However, its sales were still 75% larger than during the comparable period of fiscal 2020 ut costs were the major concern which hopefully by the end of next quartr we will se how they have managed to reduce if any.
A number of brokerages have recently commented on WG. Barclays cut their target price on shares of John Wood Group from GBX 340 ($4.06) to GBX 320 ($3.83) and set an “overweight” rating on the stock in a report on Monday, July 18th. JPMorgan Chase & Co. lifted their price objective on shares of John Wood Group from GBX 285 ($3.41) to GBX 306 ($3.66) and gave the company an “overweight” rating in a research note on Monday, May 23rd. Citigroup reiterated a “buy” rating and set a GBX 400 ($4.78) target price on shares of John Wood Group in a research note on Monday, May 9th. Finally, Berenberg Bank dropped their price target on John Wood Group from GBX 300 ($3.59) to GBX 270
Since the poor rns yesterday drop of 12;% up 5%today so down 7% isn't as bad as we all expected in my opinion.
@70% lower than July last year even breaking £1.10 is a 20% increase that we all would be happy with.
Gla